253P Risk factor (RF) identification (ID) and hyperglycemia (HG) prevention with alpelisib (ALP) + fulvestrant (FLV) in PIK3CA-mutated, hormone-receptor positive (HR+), human epidermal growth factor-2 negative (HER2-) advanced breast cancer (ABC)

Conference Paper

Full Text

Duke Authors

Cited Authors

Burnette, S; Poehlein, E; Lee, H-J; Force, J; Westbrook, K; Moore, H

Published Date

September 2021

Published In

Annals of Oncology

Volume / Issue

32 /

Start / End Page

S470 - S470

Published By

Elsevier BV

International Standard Serial Number (ISSN)

0923-7534

Digital Object Identifier (DOI)

10.1016/j.annonc.2021.08.536